Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 8081018, 10 pages
https://doi.org/10.1155/2018/8081018
Research Article

Evaluation of How Integrative Oncology Services Are Valued between Hematology/Oncology Patients and Hematologists/Oncologists at a Tertiary Care Center

1Cancer Treatment Centers of America, Atlanta, GA, USA
2Jackson Memorial Hospital, Miami, FL, USA
3Sylvester Comprehensive Cancer Center, Miami, FL, USA
4Miller School of Medicine, University of Miami, Miami, FL, USA
5University of Miami Health System, Miami, FL, USA

Correspondence should be addressed to D. M. Hansra; moc.liamg@arsnahmd

Received 5 October 2017; Revised 28 December 2017; Accepted 4 January 2018; Published 12 April 2018

Academic Editor: Konrad Urech

Copyright © 2018 D. M. Hansra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Evidence regarding opinions on integrative modalities by patients and physicians is lacking. Methods. A survey study was conducted assessing how integrative modalities were valued among hematology/oncology patients and hematologists and oncologists at a major tertiary medical center. Results. 1008 patients and 55 physicians were surveyed. With the exception of support groups, patients valued nutrition services, exercise therapy, spiritual/religious counseling, supplement/herbal advice, support groups, music therapy, and other complimentary medicine services significantly more than physicians . Conclusion. With the exception of support groups, patients value integrative modalities more than physicians. Perhaps with increasing education, awareness, and acceptance by providers and traditional institutions, integrative modalities could be equally valued between patients and providers. It is possible that increased availability and utilization of integrative oncology modalities at tertiary hospital sites could improve patient satisfaction, quality of life, and other clinical endpoints.